Rules of engagement: Molecular insights from host-virus arms races

Annual Review of Genetics

Volumn 46, Issue , 2012, Pages 677-700

  Daugherty, Matthew D ^a   Malik, Harmit S ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NUCLEOTIDE; PROTEIN KINASE R; TRIPARTITE MOTIF PROTEIN 5;

ADAPTIVE IMMUNITY; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; EPISTASIS; EVOLUTIONARY ADAPTATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC CONSERVATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; INFLUENZA VIRUS A; INNATE IMMUNITY; MOLECULAR EVOLUTION; NATURAL SELECTION; NONHUMAN; PHYLOGENY; POSITIVE SELECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PURIFYING SELECTION; SITE DIRECTED MUTAGENESIS; SOMATIC HYPERMUTATION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; CARRIER PROTEINS; CYTOSINE DEAMINASE; EPISTASIS, GENETIC; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MONOMERIC GTP-BINDING PROTEINS; PROTEOLYSIS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SELECTION, GENETIC; VIRAL PROTEINS;

MAMMALIA; PRIMATES;

EID: 84867647908     PISSN: 00664197     EISSN: 15452948     Source Type: Book Series    
DOI: 10.1146/annurev-genet-110711-155522     Document Type: Article

References (117)

1. Anisimova M, Bielawski JP, Yang Z. 2001. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol. Biol. Evol. 18:1585-92
2. Bannert N, Kurth R. 2006. The evolutionary dynamics of human endogenous retroviral families. Annu. Rev. Genomics Hum. Genet. 7:149-73
3. Belyi VA, Levine AJ, Skalka AM. 2010. Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and circoviridae are more than 40 to 50 million years old. J. Virol. 84:12458-62
4. Belyi VA, Levine AJ, Skalka AM. 2010. Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathog. 6:e1001030
5. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328:1272-75
6. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-26
7. Brennan G, Kozyrev Y, Hu SL. 2008. TRIMCyp expression in OldWorld primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. USA 105:3569-74
8. Burt A, Trivers R. 2006. Genes in Conflict: The Biology of Selfish Genetic Elements. Cambridge, MA: Belknap Press
9. Cantalupo PG, Calgua B, Zhao G, Hundesa A, Wier AD, et al. 2011. Raw sewage harbors diverse viral populations. MBio 2:e00180-11
10. CarringtonM, NelsonGW, Martin MP, Kissner T, Vlahov D, et al. 1999.HLAand HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283:1748-52
11. Chiu YL, Greene WC. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-53
12. Clackson T, Wells JA. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267:383-86
13. Compton AA, Hirsch VM, Emerman M. 2012. The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11:91-98
14. Consortium CSaA. 2005. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437:69-87
15. Conticello SG. 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9:229
16. DarAC, Dever TE, Sicheri F. 2005. Higher-order substrate recognition of eIF2αby theRNA-dependent protein kinase PKR. Cell 122:887-900
17. Dar AC, Sicheri F. 2002. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol. Cell 10:295-305
18. Demogines A, East AM, Lee JH, Grossman SR, Sabeti PC, et al. 2010. Ancient and recent adaptive evolution of primate non-homologous end joining genes. PLoS Genet. 6:e1001169
19. Dever TE, Dar AC, Sicheri F. 2007. Translational Control in Biology and Medicine. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
20. Duggal NK, Malik HS, Emerman M. 2011. The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection. J. Virol. 85:11361-71
21. Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, et al. 2012. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell. 150:831-41
22. Elde NC, Child SJ, Geballe AP, Malik HS. 2009. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457:485-89
23. Elde NC, Malik HS. 2009. The evolutionary conundrum of pathogen mimicry. Nat. Rev. Microbiol. 7:787-97
24. Emerman M, Malik HS. 2010. Paleovirology: modern consequences of ancient viruses. PLoS Biol. 8:e1000301
25. Finkbeiner SR, Allred AF, Tarr PI, Klein EJ, Kirkwood CD, Wang D. 2008. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 4:e1000011
26. Gibbs RA, Rogers J, KatzeMG, Bumgarner R, Weinstock GM, et al. 2007. Evolutionary and biomedical insights from the rhesus macaque genome. Science 316:222-34
27. Gifford RJ. 2012. Viral evolution in deep time: lentiviruses and mammals. Trends Genet. 28:89-100
28. Gilbert C, Feschotte C. 2010. Genomic fossils calibrate the long-term evolution of hepadnaviruses. PLoS Biol. 8:e1000495
29. Gilman RT, Nuismer SL, Jhwueng DC. 2012. Coevolution in multidimensional trait space favours escape from parasites and pathogens. Nature 483:328-30
30. GoldstoneDC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, et al. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-82
31. Gupta RK, Hue S, Schaller T, Verschoor E, Pillay D, Towers GJ. 2009. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443
32. Halabi N, Rivoire O, Leibler S, Ranganathan R. 2009. Protein sectors: evolutionary units of threedimensional structure. Cell 138:774-86
33. HallerO, Gao S, von der Malsburg A, Daumke O, Kochs G. 2010. Dynamin-likeMxA GTPase: structural insights into oligomerization and implications for antiviral activity. J. Biol. Chem. 285:28419-24
34. Han K, Lou DI, Sawyer SL. 2011. Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS Genet. 7:e1002388
35. Harris RS, Liddament MT. 2004. Retroviral restriction by APOBECproteins. Nat. Rev. Immunol. 4:868- 77
36. Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, et al. 1999. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections. J Virol. 73:6984-91
37. Holmes EC. 2004. Adaptation and immunity. PLoS Biol. 2:E307
38. Holmes EC. 2011. The evolution of endogenous viral elements. Cell Host Microbe 10:368-77
39. HorieM, Honda T, Suzuki Y, Kobayashi Y, Daito T, et al. 2010. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463:84-87
40. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-BrodackaM, et al. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-61
41. Hughes AL, Nei M. 1992. Maintenance of MHC polymorphism. Nature 355:402-3
42. Hurst LD. 2002. The Ka/Ks ratio: diagnosing the form of sequence evolution. Trends Genet. 18:486
43. Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, et al. 2012. Global landscape of HIV-human protein complexes. Nature 481:365-70
44. Johnson WE. 2010. Endless forms most viral. PLoS Genet. 6:e1001210
45. Johnson WE, Sawyer SL. 2009. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61:163-76
46. Kaiser SM, Malik HS, Emerman M. 2007. Restriction of an extinct retrovirus by the human TRIM5α antiviral protein. Science 316:1756-58
47. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. 2009. Tetherin-mediated restriction of filovirus budding is antagonized by the ebola glycoprotein. Proc. Natl. Acad. Sci. USA 106:2886-91
48. Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, et al. 2011. Characterization of a canine homolog of hepatitis C virus. Proc. Natl. Acad. Sci. USA 108:11608-13
49. Katzourakis A, Gifford RJ. 2010. Endogenous viral elements in animal genomes. PLoS Genet. 6:e1001191
50. Katzourakis A, Rambaut A, Pybus OG. 2005. The evolutionary dynamics of endogenous retroviruses. Trends Microbiol. 13:463-68
51. Kerns JA, Emerman M, Malik HS. 2008. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 4:e21
52. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. 2007. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 3:e63
53. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors byHIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67
54. Kirmaier A, Wu F, Newman RM, Hall LR, Morgan JS, et al. 2010. TRIM5 suppresses crossspecies transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 8: e1000462
55. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135:49-60
56. Kosiol C, Vinar T, da Fonseca RR, Hubisz MJ, BustamanteCD, et al. 2008. Patterns of positive selection in six mammalian genomes. PLoS Genet. 4:e1000144
57. Koyanagi M, Kerns JA, Chung L, Zhang Y, Brown S, et al. 2010. Diversifying selection and functional analysis of interleukin-4 suggests antagonism-driven evolution at receptor-binding interfaces. BMC Evol. Biol. 10:223
58. Laguette N, Rahm N, Sobhian B, Chable-Bessia C, Münch J, et al. 2012. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11:205-217
59. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-57
60. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, et al. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13:223-28
61. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL. 2006. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119:100-10
62. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102:17717-22
63. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. 2012. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11:194-204
64. Lim ES, Malik HS, Emerman M. 2010. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 84:7124-34
65. Lindblad-Toh K, Garber M, Zuk O, Lin MF, Parker BJ, et al. 2011. A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478:476-82
66. Malim MH, Emerman M. 2008. HIV-1 accessory proteins: ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-98
67. Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, et al. 2009. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83:9672-81
68. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. 2009. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5:e1000300
69. Medzhitov R, Schneider DS, Soares MP. 2012. Disease tolerance as a defense strategy. Science 335:936-41
70. Meyerson NR, Sawyer SL. 2011. Two-stepping through time: mammals and viruses. Trends Microbiol. 19:286-94
71. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
72. Mitchell PS, Patzina C, Emerman M, Haller O, Malik HS, Kochs G. 2012. Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe. In press
73. Moreira IS, Fernandes PA, Ramos MJ. 2007. Hot spots: a review of the protein-protein interface determinant amino-acid residues. Proteins 68:803-12
74. Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, et al. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7:e1001311
75. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-30
76. Newman RM, Hall L, Connole M, Chen GL, Sato S, et al. 2006. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc. Natl. Acad. Sci. USA 103:19134-39
77. Newman RM, Hall L, Kirmaier A, Pozzi LA, Pery E, et al. 2008. Evolution of a TRIM5-CypA splice isoform in Old World monkeys. PLoS Pathog. 4:e1000003
78. Nisole S, Stoye JP, Saib A. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808
79. Nuismer SL, Otto SP. 2004. Host-parasite interactions and the evolution of ploidy. Proc. Natl. Acad. Sci. USA 101:11036-39
80. OhAinleM, Kerns JA, Li MM, Malik HS, Emerman M. 2008. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4:249-59
81. Ohkura S, YapMW, Sheldon T, Stoye JP. 2006. All three variable regions of the TRIM5αB30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 80:8554-65
82. Patel MR, Emerman M, Malik HS. 2011. Paleovirology: ghosts and gifts of viruses past. Curr. Opin. Virol. 1:304-9
83. Patel MR, Loo YM, Horner SM, Gale M Jr, Malik HS. 2012. Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol. 10:e1001282
84. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499-511
85. Pond SL, Frost SD, Muse SV. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676- 79
86. Powell RD, Holland PJ, Hollis T, Perrino FW. 2011. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286:43596-600
87. Price AJ, Marzetta F, Lammers M, Ylinen LM, Schaller T, et al. 2009. Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat. Struct. Mol. Biol. 16:1036-42
88. Reynolds KA, McLaughlin RN, Ranganathan R. 2011. Hot spots for allosteric regulation on protein surfaces. Cell 147:1564-75
89. Rothenburg S, Seo EJ, Gibbs JS, Dever TE, Dittmar K. 2009. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat. Struct. Mol. Biol. 16:63-70
90. Sauter D, Schindler M, Specht A, Landford WN, Munch J, et al. 2009. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6:409-21
91. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNAediting enzyme APOBEC3G. PLoS Biol. 2:E275
92. Sawyer SL, Wu LI, Akey JM, Emerman M, Malik HS. 2006. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5αin humans. Curr. Biol. 16:95-100
93. Sawyer SL, Wu LI, EmermanM, Malik HS. 2005. Positive selection of primate TRIM5αidentifies a critical species-specific retroviral restriction domain. Proc.Natl. Acad. Sci. USA 102:2832-37
94. Sayah DM, Sokolskaja E, Berthoux L, Luban J. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-73
95. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-25
96. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-85
97. Sen GC, Sarkar SN. 2007. The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr. Top. Microbiol. Immunol. 316:233-50
98. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-50
99. Smith EE, Malik HS. 2009. The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res. 19:850-58
100. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5αrestricts HIV-1 infection in Old World monkeys. Nature 427:848-53
101. Stremlau M, Perron M, Welikala S, Sodroski J. 2005. Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of human immunodeficiency virus restriction. J. Virol. 79:3139-45
102. Taylor DJ, Leach RW, Bruenn J. 2010. Filoviruses are ancient and integrated intomammalian genomes. BMC Evol. Biol. 10:193
103. Van Valen L. 1973. A new evolutionary law. Evol. Theory 1:1-30
104. Venkataraman N, Cole AL, Ruchala P, Waring AJ, Lehrer RI, et al. 2009. Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol. 7:e95
105. Virgen CA, Kratovac Z, Bieniasz PD, Hatziioannou T. 2008. Independent genesis of chimeric TRIM5- cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. USA 105:3563-68
106. Wilson SJ, Webb BL, Maplanka C, Newman RM, Verschoor EJ, et al. 2008. Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J. Virol. 82:7243-47
107. Wilson SJ, Webb BL, Ylinen LM, Verschoor E, Heeney JL, Towers GJ. 2008. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. USA 105:3557-62
108. Wolf D, Goff SP. 2008. Host restriction factors blocking retroviral replication. Annu. Rev. Genet. 42:143-63
109. Yang Y, Liang Y, Qu L, Chen Z, YiM, et al. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA 104:7253-58
110. Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24:1586-91
111. YapMW, Nisole S, Stoye JP. 2005. A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction. Curr. Biol. 15:73-78
112. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. 2009. A genome-wide short hairpin RNA screening of jurkat T-cells for humanproteins contributing to productive HIV-1 replication. J. Biol.Chem. 284:19463- 73
113. Ylinen LM, Price AJ, Rasaiyaah J, Hue S, Rose NJ, et al. 2010. Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathog. 6:e1001062
114. Yokoyama S, Tada T, Zhang H, Britt L. 2008. Elucidation of phenotypic adaptations: molecular analyses of dim-light vision proteins in vertebrates. Proc. Natl. Acad. Sci. USA 105:13480-85
115. Yu X, Yu Y, Liu B, Luo K, KongW, et al. 2003. Induction ofAPOBEC3Gubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-60
116. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54-67
117. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4:495-504